Bristol NIHR Cardiovascular Biomedical Research Unit, Bristol Heart Institute, Bristol, United Kingdom.
Bristol NIHR Cardiovascular Biomedical Research Unit, Bristol Heart Institute, Bristol, United Kingdom.
Int J Cardiol. 2017 Oct 1;244:335-339. doi: 10.1016/j.ijcard.2017.06.080. Epub 2017 Jun 21.
Atrio-ventricular block (AVB) is a rare finding in young or middle-aged adults, often leading to pacemaker implantation (PM) without further investigation. We sought to assess the diagnostic role of cardiovascular magnetic resonance (CMR) in young and middle-aged adults with high-grade AVB.
We consecutively enrolled young-middle aged (18-65years) patients with high grade AVB referred to CMR after standard clinical assessment (history, electrocardiogram and cardiac rhythm monitoring) prior to PM implantation. Cine and post-contrast imaging were performed in a 1.5T scanner.
34 patients (59% male, mean age 42±12years) with high grade AVB were referred to CMR for suspected ischemic heart disease (IHD)(n=4) and non-ischemic heart disease (NIHD)(n=20); no clear cause was found in 9 patients prior to CMR and 1 patient had suspected lung disease. A pathologic substrate was found on CMR in 15 patients (44%), while a structurally normal heart was reported in 18 (53%). Non-specific findings were reported in 1 patient (3%). There was a fair agreement between CMR and echocardiographic findings (Cohen's kappa 0.243), and CMR provided an entirely new diagnosis in 34% of patients. As compared to the standard clinical assessment, CMR had an additional role in 65% of patients and guided further testing (genetic testing, extra-cardiac imaging) in 9%.
CMR found a pathologic substrate in 44% of patients, mainly NIHD (32%). Half of the patients (53%) had a structurally normal heart. When added to the standard clinical assessment, CMR had an incremental diagnostic role in two thirds of patients.
房室传导阻滞(AVB)在年轻或中年患者中较为罕见,常导致植入起搏器(PM)而无需进一步检查。我们旨在评估心血管磁共振(CMR)在年轻和中年高度房室传导阻滞患者中的诊断作用。
我们连续纳入了年轻-中年(18-65 岁)患者,这些患者在 PM 植入前通过标准临床评估(病史、心电图和心脏节律监测)转诊至 CMR 时,存在高度房室传导阻滞。在 1.5T 扫描仪上进行电影和对比增强成像。
34 例(59%为男性,平均年龄 42±12 岁)高度房室传导阻滞患者因疑似缺血性心脏病(IHD)(n=4)和非缺血性心脏病(NIHD)(n=20)转诊至 CMR;9 例患者在 CMR 前未发现明确病因,1 例患者疑似肺部疾病。15 例患者(44%)CMR 发现了病理学基础,18 例(53%)报告心脏结构正常。1 例(3%)报告非特异性发现。CMR 与超声心动图结果之间存在适度一致性(Cohen's kappa 0.243),CMR 在 34%的患者中提供了全新的诊断。与标准临床评估相比,CMR 在 65%的患者中有额外作用,并指导了进一步检查(基因检测、心脏外影像学检查)在 9%的患者中有额外作用。
CMR 在 44%的患者中发现了病理学基础,主要是 NIHD(32%)。一半的患者(53%)心脏结构正常。当与标准临床评估相结合时,CMR 在三分之二的患者中有额外的诊断作用。